Oral Syringe Market

Oral Syringe Market Size, Market Forecast and Outlook By FMI

In 2025, the oral syringe market was valued at USD 2.47 billion. Based on Future Market Insights' analysis, demand is estimated to grow to USD 2.63 billion in 2026 and USD 4.89 billion by 2036. FMI projects a CAGR of 6.40% during the forecast period.

Summary of Oral Syringe Market

• Oral Syringe Market Definition
  • Oral syringes are non-Luer-compatible, needle-free dosing devices designed for precise volume measurement and administration of liquid oral medications, available in small, medium, and large volume configurations for pediatric dosing, geriatric medication administration, post-surgical care, and dental procedure applications.
• Demand Drivers in the Market
  • Pediatric medication dosing accuracy requirements drive oral syringe adoption because infants and young children require weight-based dose volumes measured in 0.1 mL increments that dosing cups and spoons cannot accurately deliver, with AAP guidelines recommending milliliter-marked oral syringes for all pediatric liquid medications.
  • ISO 80369-3 enteral connector standard and FDA ISMP wrong-route medication error prevention initiatives mandate non-Luer oral syringe designs in hospitals, converting institutional procurement from generic Luer-tip syringes repurposed for oral use to dedicated oral-specific devices.
  • Geriatric care facility expansion in aging population demographics creates institutional oral syringe demand for administering liquid medications to patients with swallowing difficulties who cannot take solid oral dosage forms.
• Key Segments Analyzed in the FMI Report
  • Large Volume Syringe capacity: 46.8% share in 2026, reflecting its structural position as the primary category across established procurement channels.
  • Prescription order type: 67.4% share in 2026, reflecting its structural position as the primary category across established procurement channels.
  • Pediatric Care application: 41.9% share in 2026, reflecting its structural position as the primary category across established procurement channels.
  • India: 10.50% compound growth through 2036, indicating concentrated demand acceleration.
• Analyst Opinion at FMI
  • Ismail Sutaria, Principal Consultant for Packaging analysts observe that the oral syringe market is a medication delivery device category where patient safety mandates and pediatric dosing accuracy requirements are converting oral syringes from a convenience item into a compliance necessity. FMI analysts observe that large volume syringes command 46.8% capacity share because adult medication doses and pediatric suspension volumes frequently exceed the 5 mL upper range of small oral syringes. Prescription at 67.4% order type share confirms that physician-directed medication dosing generates the majority of oral syringe consumption. Pediatric care at 41.9% application share leads because weight-based dosing precision for children is the clinical use case where oral syringe accuracy provides the most measurable patient safety benefit. India leads at 10.5% CAGR because expanding pediatric healthcare infrastructure and government immunization programme oral vaccine delivery are creating concentrated institutional procurement.
• Strategic Implications / Executive Takeaways
  • Oral syringe manufacturers must achieve ISO 80369-3 compliance certification for non-Luer oral connectors to qualify for hospital procurement programmes mandating wrong-route prevention device specifications.
  • Hospital pharmacy directors should standardize oral syringe procurement on amber-tipped, milliliter-marked designs to simultaneously address light-sensitive medication protection and dosing accuracy requirements in a single device specification.
  • Pediatric oral medication manufacturers should co-package oral syringes with liquid formulations to improve dosing accuracy at the point of administration, reducing the reliance on caregivers to source and correctly use separate dosing devices.

The market is set to add approximately USD 2.26 billion in absolute terms between 2026 and 2036. Pediatric medication dosing accuracy requirements and medication safety initiatives mandating oral-specific (non-Luer) syringe designs are the primary demand drivers. Hospital patient safety programmes and WHO medication safety recommendations are converting oral liquid medication administration from cup-based estimation to syringe-based precision dosing, with regulatory mandates in the USA and EU requiring non-injectable oral syringe designs to prevent wrong-route administration errors.

As per FMI, country-level growth rates through 2036 are projected as follows: India at 10.50%, China at 9.40%, South Africa at 9.00%, KSA at 7.90%, Japan at 7.50%, Brazil at 7.10%, Mexico at 6.60%, Canada at 6.40%, UK at 5.40%, USA at 5.30%, France at 4.80%, Germany at 4.00%. India records the fastest expansion driven by concentrated industry investment.

Oral Syringe Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 2.63 Billion
Industry Value (2036)	USD 4.89 Billion
CAGR (2026 to 2036)	6.40%

Source: Future Market Insights, 2026

Oral Syringe Market Definition

The oral syringe market encompasses needle-free, non-Luer-compatible dosing devices engineered for precise volume measurement and administration of liquid oral medications. Product configurations span small volume (1 to 3 mL), medium volume (5 to 10 mL), and large volume (10 to 60 mL) oral syringes with clear or amber barrels, milliliter graduation markings, and oral-specific tip designs preventing connection to intravenous access lines. FMI is of the opinion that the market is transitioning from a convenience dosing accessory to a patient safety compliance device, driven by ISO 80369-3 connector standards and hospital medication error prevention programmes that mandate dedicated oral-specific syringe designs.

Oral Syringe Market Inclusions

Market scope covers large, medium, and small volume oral syringes sold through prescription and OTC channels for pediatric care, geriatric medication administration, post-surgical and critical care dosing, and dental procedure applications across institutional and retail distribution.

Oral Syringe Market Exclusions

Hypodermic (Luer-compatible) injection syringes, insulin pen devices, pre-filled parenteral syringes, and enteral feeding syringes with ENFit connectors are excluded.

Oral Syringe Market Research Methodology

• Primary Research: Analysts conducted structured interviews with procurement managers, product engineers, and distribution channel operators to map purchase decision triggers and specification requirements across key verticals.
• Desk Research: Data collection aggregated regulatory filings, industry standards documentation, patent registries, trade body publications, and company annual reports across all target geographies.
• Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation of product shipment volumes and average selling prices, validated against publicly disclosed revenue figures from leading suppliers.
• Data Validation and Update Cycle: Projections are cross-referenced against quarterly earnings data, import-export trade statistics, and industry association production reports to maintain forecast integrity.

Analysis of Historical Trends that Impacted Global Oral Syringe Market Growth

Factors such as the increased number of daycare surgeries, high birth rates, and growing adoption of oral syringes fueled growth of the syringe market. Also, the number of premature neonates in Neonatal Intensive Care Units (NICU) affected the market during 2021 and 2025.

The market is not just growing but also evolving in a sustainable direction. It promotes a circular economy by utilizing eco-friendly and recycled materials and implementing sustainable business models to reduce environmental impact. This commitment to sustainability is not only commendable but also inspiring.

Market Dynamics Influencing Oral Syringe Sales

Challenges with Pill Swallowing Fueling Demand

The increasing prevalence of chronic diseases increases the demand for oral syringes. Patients suffering from these diseases need medication management for the long term to control the symptoms and related complications.

Individuals with asthma, diabetes, or hypertension take medication daily, which calls for precise equipment, fueling demand for oral syringes. A dependable method of administering medication in specified amounts is with the help of oral syringes.

Shift towards Home Healthcare Services

The healthcare sector is shifting towards home treatment for health issues. Individuals are getting nursing, medical, and personal care services from professionals in the comfort of their homes. The need for home healthcare services is rising due to the increasing aging population worldwide.

For usage at home, patients require readily available and simple-to-operate gadgets. Disposable oral syringes are a practical tool for self-administration, providing accurate medication dosing and making them the best option for self-care. They are gaining traction among consumers since they are necessary for patient-centered, individualized in-home healthcare.

Category-wise Insights

The below table highlights how large volume syringe segment is leading the market in terms of capacity. It is set to grow at a CAGR of 7.5% through 2034. Based on order type, the OTC (over the counter) segment is projected to record a CAGR of 7.3% through 2036.

Demand to Remain High for Large Volume Oral Syringes

Capacity	Value CAGR
Medium Volume Syringe (10 to 20 ml)	6.0%
Large Volume Syringe (Above 20ml)	7.5%

Demand for large-volume oral syringes with a capacity above 20 ml is estimated to grow with a CAGR of 7.5%, totaling a market valuation of USD 1,580.1 million by 2036. Large-volume syringes offer convenience to patients with easy and controlled administration of liquid medications. They are prominently used in healthcare facilities for patients of different age groups and medical needs.

Prescription Segment Claims the Top Spot

Order Type	Value CAGR
OTC (Over the Counter)	7.3%
Prescription	5.9%

As per the latest analysis, prescription-based segment is set to dominate the market with a share of 67.4% in 2026. Further, it will grow at a CAGR of 5.9% during the projection period, totaling a valuation of USD 1,955.8 million by 2036.

Oral syringes are widely utilized in prescription-based medicine due to their safety and precise dosing. The healthcare sector's strict regulations are causing several medications to be unavailable without a prescription, increasing the demand for prescription-based syringes.

On the other hand, the OTC segment is anticipated to grow at a higher CAGR of 7.3% during the assessment period. This can be attributed to growing consumer interest in OTC medicines and medical devices due to multiple advantages.

Country-wise Analysis

This section will detail the market in key countries, including the United States, Germany, the United Kingdom, Japan, China, and India. It will emphasize the various reasons propelling the growth of oral syringe industry in the countries mentioned below.

Countries	Value CAGR (2026 to 2036)
United States	5.3%
Canada	6.4%
Brazil	7.1%
Mexico	6.6%
Germany	4.0%
France	4.8%
United Kingdom	5.4%
China	9.4%
India	10.5%
Japan	7.5%
KSA	7.9%
South Africa	9.0%

Surging Geriatric Population in Japan Fuels Demand

Japan is set to record a CAGR of 7.5% in the assessment year, propelled by an increasing number of elderly citizens, resulting in increased healthcare needs. Japan's oldest population, 1 in 10 people aged 80 or older, necessitates frequent healthcare services.

Oral syringes filled with liquid drugs are a safer and more convenient option for elderly patients who struggle with swallowing pills or tablets. These sophisticated medicine delivery methods are essential for managing chronic illnesses that often affect the elderly, making them a safer and more convenient choice in Japan.

High Prevalence of Chronic Diseases in the United States Presents Growth Opportunity

The United States market is projected to advance at a CAGR of 5.3% from 2026 to 2036. This can be attributed to increasing prevalence of chronic illnesses requiring frequent treatment and the need for precise dose distribution, especially in pediatric and geriatric patients.

To correctly deliver liquid drugs in healthcare settings, oral syringes are frequently utilized, especially for patients who have difficulties swallowing tablets or for babies and young children. Thus, a spike in chronic diseases like cardiovascular disease, diabetes, and arthritis will continue to provide impetus for market growth in the United States.

Competitive Landscape in Oral Syringe Market

Leading companies in the industry are working on innovative designs to enhance accuracy, convenience, and ease of use. Manufacturing companies are collaborating with pharmaceutical companies to develop syringes for consumer needs. Recent activities and developments implemented by the leading manufacturers and companies in the market.

Key Companies Profiled

• Adelphi Healthcare Packaging
• Schott AG
• Gerresheimer AG
• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• DWK Life Sciences GmbH
• Vetter Pharma International GmbH
• Comar, LLC
• Baxter International Inc.
• TOPAS Advanced Polymers, Inc.
• Dentsply Sirona
• Septodont
• Terumo Corporation
• Merit Medical Systems, Inc.
• Plas-Tech Engineering
• B. Braun Melsungen
• Medtronic plc
• Smiths Medical, Inc.
• NIPRO Corporation
• Integra LifeSciences

Scope of the Report

Metric	Value
Quantitative Units	USD 2.63 Bn to USD 4.89 Bn, at a CAGR of 6.40%
Market Definition	Oral syringes are non-Luer-compatible, needle-free dosing devices designed for precise volume measurement and administration of liquid oral medications, available in small, medium, and large volume configurations for pediatric dosing, geriatric medication administration, post-surgical care, and dental procedure applications.
Capacity Segmentation	Large Volume Syringe, Medium Volume Syringe, Small Volume Syringe
Order Type Segmentation	Prescription, OTC
Application Segmentation	Pediatric Care, Geriatric Care, Post-Surgery/Critical Care, Dental Procedures, Others
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	India, China, South Africa, KSA, Japan, Brazil, Mexico, Canada, UK, USA, France, Germany, and 40 plus countries
Key Companies Profiled	Becton, Dickinson and Company, Adelphi Healthcare Packaging, Schott AG, Gerresheimer AG, West Pharmaceutical Services, Inc., DWK Life Sciences GmbH, Vetter Pharma International GmbH, Comar, LLC, Baxter International Inc., Dentsply Sirona, Terumo Corporation, Merit Medical Systems, Inc., B. Braun Melsungen, Medtronic plc, NIPRO Corporation, Integra LifeSciences
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down modeling validated against primary research inputs and publicly available industry data.

Market Segmentation

By Capacity:

• Small Volume Syringe (1 to 10 ml)
• Medium Volume Syringe (10 to 20 ml)
• Large Volume Syringe (Above 20ml)

By Order Type:

• OTC (Over the Counter)
• Prescription

By Sales Channel :

• Institutional Sales
  • Hospitals/Clinics
  • Public health Agencies
  • Diagnostic Centers
  • Research & Development Centers
• Retail Sales
  • Retail Pharmacies/Supermarket
  • Drug Store
• E-Commerce/Online Platform

By Application:

• Pediatric Care
• Geriatric Care
• Post-Surgery/Critical Care
• Dental Procedures
• Others (Home Healthcare, Enteral Nutrition)

By Region:

• North America
• Latin America
• East Asia
• South Asia & Pacific
• Western Europe
• Eastern Europe
• Middle East and Africa

Bibliography

• [1] International Organization for Standardization. (2024). ISO 80369-3: Small-Bore Connectors for Liquids and Gases, Enteral Applications. ISO.
• [2] US Food and Drug Administration. (2024). Guidance for Industry: Safety Considerations for Container Labels and Carton Labeling, Oral Dosing Devices. FDA.
• [3] American Academy of Pediatrics. (2024). AAP Policy Statement: Metric Dosing of Liquid Medications for Children. AAP.
• [4] Becton, Dickinson and Company. (2024). Annual Report 2024: Medical Segment, Medication Delivery Solutions. BD.
• [5] World Health Organization. (2024). Medication Without Harm: WHO Global Patient Safety Challenge. WHO.

This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.